Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,802 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia.
Konnikova L, Robinson TO, Owings AH, Shirley JF, Davis E, Tang Y, Wall S, Li J, Hasan MH, Gharaibeh RZ, Mendoza Alvarez LB, Ryan LK, Doty A, Chovanec JF, O'Connell MP, Grunes DE, Daley WP, Mayer E, Chang L, Liu J, Snapper SB, Milner JD, Glover SC, Lyons JJ. Konnikova L, et al. J Allergy Clin Immunol. 2021 Sep;148(3):813-821.e7. doi: 10.1016/j.jaci.2021.04.004. Epub 2021 Apr 15. J Allergy Clin Immunol. 2021. PMID: 33865872 Free PMC article.
Determination of iodine content in foods produced by family farmers.
Lopes SO, Mayer EM, Oliveira SS, Bitencourt JM, Fontes EAF, Santos RHS, Franceschini SDCC, Priore SE. Lopes SO, et al. Among authors: mayer em. Cien Saude Colet. 2026 Jul;31(7):e09722024. doi: 10.1590/1413-81232026317.09722024. Epub 2025 Apr 9. Cien Saude Colet. 2026. PMID: 42561223 Free article. English, Portuguese.
Combination of Measurements of CP Properties of Higgs Boson Interactions with Vector Bosons Using Proton-Proton Collisions at sqrt[s]=13  TeV with the ATLAS Detector.
Aad G, Aakvaag E, Abbott B, Abdelhameed S, Abeling K, Abicht NJ, Abidi SH, Aboelela M, Aboulhorma A, Abramowicz H, Acharya BS, Ackermann A, Adam Bourdarios C, Adamczyk L, Addepalli SV, Addison MJ, Adelman J, Adiguzel A, Adye T, Affolder AA, Afik Y, Agaras MN, Aggarwal A, Agheorghiesei C, Ahmad A, Ahmadov F, Ahuja S, Ahuja S, Ai X, Aielli G, Aikot A, Ait Tamlihat M, Åkesson TPA, Akiyama D, Akolkar NN, Aktas S, Alberghi GL, Albert J, Alberti U, Albicocco P, Alderweireldt S, Alegria ZL, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi F, Algren M, Alhroob M, Ali B, Ali HMJ, Ali S, Alibocus SW, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allen DR, Allen JS, Allen JF, Alley CS, Almazan ER, Aloisio A, Alonso F, Alpigiani C, Alvarez Fernandez A, Alves Cardoso M, Alviggi MG, Aly M, Amaral Coutinho Y, Amelung C, Amerl M, Amezza T, Amini B, Amirie K, Amirkhanov A, Amperiadou D, An S, Anastopoulos C, Andeen T, Anders JK, Anderson AC, Andreazza A, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Antipov E, Antonelli M, Anulli F, Aoki M, Aoki T, Aparo MA, Aperio Bella L, Apicella M, Appelt C, Apyan A, Arampatzi M, Arbiol Val SJ, Arcangeletti C, Arce ATH, Arcuri M, Arguin… See abstract for full author list ➔ Aad G, et al. Among authors: mayer e. Phys Rev Lett. 2026 Jul 10;137(2):021801. doi: 10.1103/54vv-lgc7. Phys Rev Lett. 2026. PMID: 42503122
Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases.
Grinda T, Heiling HM, Tayob N, Smith KL, Davis R, Cotter C, DeMeo MK, Santa-Maria CA, Van Poznak C, Moy B, Brufsky AM, Melisko ME, O'Sullivan CC, Isaacs C, Rauf Y, Nangia JR, Burns RT, Savoie J, Wolff AC, Winer EP, Mayer EL, Tolaney SM, Rimawi MF, Ruddy KJ, Rocque G, Krop IE, Lin NU, Freedman RA. Grinda T, et al. Among authors: mayer el. Breast. 2026 Jul 20;89:104881. doi: 10.1016/j.breast.2026.104881. Online ahead of print. Breast. 2026. PMID: 42501479 Free article.
SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy.
Brufsky A, Park YH, Bidard FC, Mayer EL, Janni W, Ma C, Cristofanilli M, Bianchini G, Iwata H, Fasching PA, Nowecki Z, Pascual J, Chen SC, Moreau L, Ruiz-Borrego M, Shai A, Karadurmus N, Jung KH, Kikawa Y, Baird RD, Habash R, Sugarman R, Fox S, Selvi Miralles M, Huang Bartlett C, Turner N. Brufsky A, et al. Among authors: mayer el. Oncologist. 2026 Aug 6;31(9):oyag278. doi: 10.1093/oncolo/oyag278. Oncologist. 2026. PMID: 42496653 Free PMC article. Clinical Trial.
Maize-based polyculture, not monoculture, sustained precolonial societies in the Brazilian Cerrado.
Chim E, Fernandes HLA, Viana SA, Straioto H, Mayer E, Huesges S, Scott E, Mendes DT, Zardo DR, Stríkis NM, Henriques G, de Souza RL, Correia MA, Nicolau LC, Rocha ES, Koole E, Rodrigues JC, Lima T, Liryo A, Isnardis A, Bueno L, de S Santos J, Etchevarne C, Alves MA, Prous A, Steinhof A, da Cruz Júnior FW, Ilgner J, Fernandes R, Roberts P, Strauss A. Chim E, et al. Among authors: mayer e. Sci Adv. 2026 Jul 17;12(29):eaef7066. doi: 10.1126/sciadv.aef7066. Epub 2026 Jul 15. Sci Adv. 2026. PMID: 42455929 Free PMC article.
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.
Turner NC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, Kalinsky K, Iwata H, Chia S, Brufsky AM, Fasching PA, Nowecki Z, Pascual J, Karadurmus N, Gal-Yam E, Chung WP, Im SA, Zambelli A, Dalenc F, Oliveira M, Ishiguro H, Huang CS, Klinowska T, Fox S, Morrow C, Robert L, Huang-Bartlett C, Bidard FC. Turner NC, et al. Among authors: mayer el. Lancet Oncol. 2026 Aug;27(8):941-958. doi: 10.1016/S1470-2045(26)00287-1. Epub 2026 Jul 13. Lancet Oncol. 2026. PMID: 42442380
1,802 results